Spots Global Cancer Trial Database for neoadjuvant therapy
Every month we try and update this database with for neoadjuvant therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) | NCT03816475 | Myxoid Liposarc... | Hypofractionate... | 18 Years - | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. | NCT06376773 | Advanced Gastri... Neoadjuvant The... Multi-omics Ana... | combination che... | 18 Years - 80 Years | Fujian Medical University | |
| Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement | NCT00537823 | Colorectal Canc... Metastases | Cetuximab Bevacizumab Leucovorin Oxaliplatin Fluorouracil | 18 Years - | Washington University School of Medicine | |
| Combination Chemotherapy in Treating Children With Neuroblastoma | NCT00003093 | Neuroblastoma | filgrastim sargramostim carboplatin cyclophosphamid... doxorubicin hyd... etoposide conventional su... neoadjuvant the... | - 20 Years | Children's Oncology Group | |
| Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCC | NCT05516589 | Head and Neck S... | Nab-paclitaxel Cisplatin Tislelizumab Afatinib | 18 Years - | West China Hospital | |
| Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLC | NCT05987826 | Non-Small Cell ... | Furmonertinib | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. | NCT05948449 | Gastric Cancer | S-1, Oxaliplati... | 18 Years - 75 Years | Sichuan University | |
| Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma | NCT06304350 | Esophageal Canc... | Combination of ... | 18 Years - 75 Years | Tongji University | |
| NSABP Biospecimen Discovery Project | NCT01850628 | Breast Cancer | Paclitaxel trastuzumab pertuzumab | 18 Years - | NSABP Foundation Inc | |
| Toripalimab With or Without Celecoxib as Neoadjuvant Therapy in Resectable dMMR/MSI-H Colorectal Cancer | NCT03926338 | Colorectal Canc... Mismatch Repair... Microsatellite ... Neoadjuvant The... | Cohort 1: Neoad... Cohort 1: Neoad... Cohort 2: Neoad... Cohort 2: Neoad... | 18 Years - 100 Years | Sun Yat-sen University | |
| Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer | NCT05318794 | Gastric Cancer Peritoneal Meta... Chemotherapy Ef... | Doxorubicin and... | - | Imperial College London | |
| Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery | NCT00258297 | Esophageal Canc... | gefitinib conventional su... enzyme inhibito... neoadjuvant the... protein tyrosin... surgery | 18 Years - | University of Rochester | |
| Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer | NCT00084591 | Colorectal Canc... | capecitabine conventional su... neoadjuvant the... radiation thera... | 18 Years - | Fox Chase Cancer Center | |
| Phase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial | NCT05165225 | Breast Cancer HER2-low-expres... Hormone Recepto... Neoadjuvant The... | Pyrotinib + epi... | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery | NCT00057798 | Lung Cancer | gemcitabine hyd... vinorelbine dit... cytogenetic ana... loss of heteroz... microarray anal... conventional su... neoadjuvant the... | 18 Years - | Roswell Park Cancer Institute | |
| Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China | NCT03437837 | Breast Cancer Neoadjuvant The... Neoplasm Stagin... Estrogen Recept... Histological Gr... HER2 Prognosis Predictive Valu... | 18 Years - 75 Years | Peking University First Hospital | ||
| Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1 | NCT05593458 | Locally Advance... | Oxaliplatin by ... SOX neoadjuvant Sintilimab neoa... gastrectomy plu... SOX adjuvant, S... Sintilimab adju... | 18 Years - 75 Years | Zhejiang University | |
| Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ | NCT00388115 | Breast Cancer | conventional su... neoadjuvant the... radiofrequency ... | 18 Years - | University of California, Davis | |
| Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma | NCT00025428 | Neuroblastoma | carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... adjuvant therap... conventional su... neoadjuvant the... | 1 Year - 18 Years | National Cancer Institute (NCI) | |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | NCT00667901 | Melanoma (Skin) | riluzole protein express... reverse transcr... western blottin... immunohistochem... laboratory biom... pharmacological... neoadjuvant the... therapeutic con... | 18 Years - | Rutgers, The State University of New Jersey | |
| PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery | NCT00276523 | Head and Neck C... | PEG-interferon ... Conventional su... Neoadjuvant the... | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer | NCT00482222 | Colorectal Canc... Metastatic Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin study of socioe... adjuvant therap... neoadjuvant the... quality-of-life... | 18 Years - | University of Southampton | |
| Study Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma | NCT03979066 | Pancreatic Duct... | Atezolizumab PEGPH20 | 18 Years - 99 Years | Columbia University | |
| GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | NCT00262808 | Colorectal Canc... | sargramostim fluorouracil leucovorin calc... oxaliplatin adjuvant therap... conventional su... neoadjuvant the... | 18 Years - | University of Rochester | |
| Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00062322 | Lung Cancer | cisplatin irinotecan hydr... conventional su... neoadjuvant the... radiation thera... | 18 Years - | Fox Chase Cancer Center | |
| Translational Research on Locally Advanced Pancreatic Adenocarcinoma | NCT03009253 | Pancreatic Canc... | order of treatm... | 18 Years - 70 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer | NCT04553939 | Urothelial Carc... Bladder Cancer | Toripalimab Gemcitabine | 18 Years - 75 Years | Henan Cancer Hospital | |
| Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx | NCT00002839 | Head and Neck C... | cisplatin fluorouracil conventional su... neoadjuvant the... radiation thera... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery | NCT00057798 | Lung Cancer | gemcitabine hyd... vinorelbine dit... cytogenetic ana... loss of heteroz... microarray anal... conventional su... neoadjuvant the... | 18 Years - | Roswell Park Cancer Institute | |
| S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer | NCT00134095 | Gastric Cancer | irinotecan hydr... tegafur-gimerac... adjuvant therap... conventional su... neoadjuvant the... | 20 Years - 75 Years | National Cancer Institute (NCI) | |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | NCT00667901 | Melanoma (Skin) | riluzole protein express... reverse transcr... western blottin... immunohistochem... laboratory biom... pharmacological... neoadjuvant the... therapeutic con... | 18 Years - | Rutgers, The State University of New Jersey | |
| Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients | NCT05171335 | Hepatocellular ... | Lenvatinib Transcatheter A... | 18 Years - | The Methodist Hospital Research Institute | |
| Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients | NCT04696939 | Small-cell Lung... Neoadjuvant The... | Atezolizumab Carboplatin Etoposide | 18 Years - 75 Years | Shanghai Pulmonary Hospital, Shanghai, China | |
| Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma | NCT00036972 | Brain and Centr... | cintredekin bes... adjuvant therap... conventional su... neoadjuvant the... | 18 Years - | National Cancer Institute (NCI) | |
| Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer | NCT00020735 | Prostate Cancer | toremifene conventional su... neoadjuvant the... | 18 Years - 120 Years | University of Pittsburgh | |
| Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients | NCT04696939 | Small-cell Lung... Neoadjuvant The... | Atezolizumab Carboplatin Etoposide | 18 Years - 75 Years | Shanghai Pulmonary Hospital, Shanghai, China | |
| Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | NCT01107639 | Adenocarcinoma ... Esophageal Canc... | cetuximab cisplatin docetaxel adjuvant therap... neoadjuvant the... | 18 Years - 75 Years | Swiss Group for Clinical Cancer Research | |
| Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | NCT00047138 | Kidney Cancer | dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 18 Years | National Cancer Institute (NCI) | |
| Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | NCT00462397 | Cervical Cancer | carboplatin cisplatin paclitaxel neoadjuvant the... brachytherapy radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma | NCT00645632 | Sarcoma | cisplatin doxorubicin hyd... ifosfamide methotrexate adjuvant therap... neoadjuvant the... therapeutic con... | - | Mayo Clinic | |
| Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma | NCT00354393 | Malignant Mesot... | Cisplatin Methotrexate Vinorelbine dit... Adjuvant therap... Conventional su... Neoadjuvant The... 3-dimensional c... Intensity-modul... | - 75 Years | The Cleveland Clinic | |
| Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery | NCT00513266 | Colorectal Canc... Metastatic Canc... | bevacizumab cetuximab fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin laboratory biom... adjuvant therap... biopsy conventional su... neoadjuvant the... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| A Study for the Neoadjuvant Treatment of Breast Cancer | NCT05420454 | Breast Cancer | Docetaxel Carboplatin Trastuzumab Pertuzumab Nab paclitaxel Epirubicin Cyclophosphamid... Docetaxel Epirubicin Cyclophosphamid... Nab paclitaxel | 18 Years - | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer | NCT05843292 | Triple-negative... | Taxane and Carb... Short-term Sint... Surgery | 18 Years - 70 Years | Shanghai Jiao Tong University School of Medicine | |
| Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer | NCT00088829 | Breast Cancer | paclitaxel microarray anal... biopsy neoadjuvant the... Paclitaxel | 18 Years - | Georgetown University | |
| Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer | NCT05241340 | Urothelial Carc... | Sasanlimab Stereotactic Bo... Radical Cystect... | 18 Years - | The Methodist Hospital Research Institute | |
| Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer | NCT00438737 | Colorectal Canc... Metastatic Canc... | bevacizumab cetuximab fluorouracil leucovorin calc... oxaliplatin adjuvant therap... conventional su... neoadjuvant the... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy | NCT04085250 | Stage III Non-s... | Neoadjuvant the... Chemotherapy co... Radiotherapy Nivolumab Observation | 18 Years - 75 Years | Sun Yat-sen University | |
| Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma | NCT05476380 | Esophageal Carc... | camrelizumab | 18 Years - 70 Years | Tianjin Medical University Cancer Institute and Hospital | |
| PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma | NCT06125223 | Squamous Cell C... Neoadjuvant The... Immunotherapy | 18 Years - 80 Years | Xijing Hospital | ||
| Exercise to Prevent AnthrCycline-based Cardio-Toxicity Study | NCT02471053 | Neoplasms Heart; Disease,... Inflammation | Moderate Intens... | 18 Years - 65 Years | Nova Scotia Health Authority | |
| Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy | NCT03417622 | Breast Cancer | Bracketing Neoadjuvant the... Post-treatment ... Pre-treatment v... | 18 Years - | Mansoura University | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain | NCT00293358 | Brain and Centr... | carboplatin cisplatin etoposide phosp... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - | National Cancer Institute (NCI) | |
| Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer | NCT05371197 | Colorectal Canc... Mismatch Repair... Microsatellite ... Neoadjuvant The... | Neoadjuvant the... | 18 Years - 70 Years | Third Affiliated Hospital, Sun Yat-Sen University | |
| Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma | NCT00334854 | Childhood Malig... Sarcoma | doxorubicin hyd... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Clip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant Therapy | NCT04468113 | Primary Breast ... | Tumark® Vision ... | 18 Years - | Kliniken Essen-Mitte | |
| Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma | NCT05024266 | Lung Squamous C... Neoadjuvant The... Immunotherapy | Tislelizumab | 18 Years - 75 Years | First Affiliated Hospital of Zhejiang University | |
| The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer | NCT05352165 | Neoadjuvant The... | standard long-t... FOLFOX and stan... FOLFIRI and sta... 5-FU and standa... 5-FU and pembro... Other individua... | 18 Years - 75 Years | Shanghai Minimally Invasive Surgery Center | |
| Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors | NCT01204801 | Breast Cancer | Focused Microwa... Chemotherapy (c... | 18 Years - | Medifocus, Inc. | |
| Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer | NCT06385912 | Ovarian Cancer Postoperative C... Neoadjuvant The... Lymph Node Exci... | lymphadenectomy | - | Tongji Hospital | |
| Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer | NCT00244920 | Prostate Cancer | bicalutamide leuprolide acet... squalamine lact... adjuvant therap... antiandrogen th... antiangiogenesi... conventional su... neoadjuvant the... releasing hormo... | 18 Years - | OHSU Knight Cancer Institute | |
| Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | NCT00533936 | Breast Cancer | trastuzumab cyclophosphamid... doxorubicin hyd... fluorouracil paclitaxel adjuvant therap... conventional su... neoadjuvant the... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Divestment for Artery-involved Pancreatic Cancer | NCT03443921 | Pancreatic Canc... Locally Advance... Neoadjuvant The... Borderline Rese... | Artery Divestme... Nab-paclitaxel | 18 Years - 80 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma | NCT00822848 | Sarcoma | epirubicin hydr... ifosfamide sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... adjuvant therap... neoadjuvant the... therapeutic con... hypofractionate... | 15 Years - 120 Years | OHSU Knight Cancer Institute | |
| Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology | NCT05441098 | Breast Cancer | Neoadjuvant the... | 18 Years - | ChineseAMS | |
| Adbelizumab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer | NCT06177522 | Pancreatic Canc... Neoadjuvant The... | Adbelimumab albumin-bound p... Gemcitabine | 18 Years - 80 Years | Jinling Hospital, China | |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall | NCT03651375 | Sarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma Myosarcoma Histiocytic Sar... Synovial Sarcom... Lymphangiosarco... Malignant Perip... Myxofibrosarcom... Myxoid Liposarc... Undifferentiate... Pleomorphic Lip... Undifferentiate... Dedifferentiate... Pleomorphic Rha... Malignant Trito... | Sequential chem... Hypofractionate... | 18 Years - 100 Years | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | NCT00025389 | Lung Cancer | bevacizumab carboplatin paclitaxel conventional su... neoadjuvant the... | 18 Years - | University of Chicago | |
| Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer | NCT00044993 | Breast Cancer | Ad5CMV-p53 gene docetaxel doxorubicin hyd... conventional su... neoadjuvant the... | 18 Years - | National Cancer Institute (NCI) | |
| A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate Cancer | NCT05376722 | Neoadjuvant The... | pamiparib abiraterone prednisone | 18 Years - 80 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer | NCT00427245 | Breast Cancer Infertility Menopausal Symp... | cyclophosphamid... goserelin aceta... adjuvant therap... fertility asses... neoadjuvant the... | - | National Cancer Institute (NCI) | |
| Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | NCT00742924 | Sarcoma | cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate zoledronic acid adjuvant therap... neoadjuvant the... therapeutic con... filgrastim Mesna | - 40 Years | Children's Oncology Group | |
| Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer | NCT05882513 | NSCLC Neoadjuvant The... | Serplulimab and... surgical resect... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery | NCT00652860 | Metastatic Canc... Sarcoma | aerosol sargram... sargramostim cisplatin doxorubicin hyd... ifosfamide mitomycin C flow cytometry immunological d... laboratory biom... adjuvant therap... multimodality t... neoadjuvant the... therapeutic con... intraoperative ... selective exter... | 18 Years - | Mayo Clinic | |
| Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC | NCT04541251 | Lung Cancer, No... Artificial Inte... | Camrelizumab + ... | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer | NCT00054106 | Prostate Cancer | buserelin custirsen sodiu... flutamide conventional su... neoadjuvant the... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer | NCT03615170 | Rectal Neoplasm... Neoadjuvant The... Circulating Tum... | 18 Years - 80 Years | Zhejiang Cancer Hospital | ||
| Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | NCT00398489 | Breast Cancer | trastuzumab anastrozole cyclophosphamid... docetaxel epirubicin hydr... goserelin aceta... tamoxifen citra... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer | NCT04973293 | Lung Neoplasm M... | sintilimab bevacizumab | 18 Years - 75 Years | Ruijin Hospital | |
| Neoadjuvant Cadonilimab in Combination With Cisplatin and Nab-paclitaxel in Resectable Head and Neck Squamous Cell Carcinoma | NCT06023875 | Head and Neck S... Locally Advance... | Cadonilimab Docetaxel Cisplatin | 18 Years - 70 Years | Sun Yat-sen University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
